Postischemic Deactivation of Cardiac Aldose Reductase

Aldose reductase modulates cardiac glycogen synthase kinase-3β

28 29 Objective: Earlier studies have demonstrated that aldose reductase (AR) plays a key role in 30 mediating ischemia-reperfusion (I/R) injury. Our objective was to investigate if AR mediates I/R 31 injury by influencing phosphorylation of glycogen synthase kinase 3β (p-GSK3β). 32 Methods: We utilized three separate models to study the effects of stress injury on the heart. 33 Hearts isolated...

Topical aldose reductase inhibitor.

amblyopia: a comprehensive survey of outcome. Eye 1992; 6: 300-4. 7 Lithander J, Sjorstrand J. Anisometropic and strabismic amblyopia in the age group 2 years and above: a prospective study of the results of treatment. retinoscopy by used to screen infants for amblyopia? A longitudinal study of refraction in the first year of life. Polymegathism is a term used to describe increased variability ...

The aldose reductase controversy.

ext to the debate as to whether chronic hyperglycemia is the primary cause of the late vascular complications of diabetes, the longest running controversy among researchers and clinicians studying this disease is the role of the sorbitol pathway, particularly its initial enzymatic step, the reduction of glucose to sorbitol by aldose reductase in the pathogenesis of these complications. Because ...

Aldose Reductase in The Retina

Aldose reductase (E.C. 1.1.1.21), an intracellular enzyme of polyol pathway, catalyzes NADPHdependent reduction of glucose to sorbitol. Under normoglycemia, most of the cellular glucose is phosphorylated into glucose-6-phosphate by hexokinase. A minor part of non-phosphorylated glucose enters the polyol pathway, the alternate route of glucose metabolism. However, under hyperglycemia, because of...

Current status of aldose reductase inhibitors.